Plastic Surgery Doctors in Edinburg, TX Accepting Medicare

1 Plastic Surgery doctors found. Showing 1 - 1

David Aubrey Lee, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2505 Cornerstone Blvd, Edinburg, TX 78539 Phone: 956-627-2878    Fax: 956-627-3702

News Archive

HSS develops new surgery for stage IV flat foot deformity

A surgery developed at Hospital for Special Surgery can improve patient outcomes in individuals with severe adult flat foot deformity, a problem that is increasingly being seen in hospitals across the country. Patients who undergo the new surgery have better long-term outcome and mobility than those who undergo traditional surgery. The paper will be presented at the annual meeting of the American Orthopaedic Foot and Ankle Society (AOFAS, abstract 348) in National Harbor, Md., on July 8.

USS more successful in removing palpable breast tumours

In a randomised controlled trial, researchers in The Netherlands have found that the use of ultrasound-guided surgery to remove tumours from women who have palpable breast cancer is much more successful than standard surgery in excising all the cancerous tissue while sparing as much healthy tissue as possible.

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.

Multifactorial approach needed for early bipolar detection

At-risk states for bipolar disorder require a multifaceted approach to be identified and appropriately treated, according to preliminary results from the Dresden High-Risk Project.

FDA lifts hold, allows Geron to proceed with Phase I clinical trial of GRNOPC1 in spinal cord injury

Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.

Read more Medical News

› Verified 3 days ago